89 related articles for article (PubMed ID: 27452288)
1. Colon Cancer in the Land of NOD: NLRX1 as an Intrinsic Tumor Suppressor.
Lei A; Maloy KJ
Trends Immunol; 2016 Sep; 37(9):569-570. PubMed ID: 27452288
[TBL] [Abstract][Full Text] [Related]
2. NLRX1 Acts as an Epithelial-Intrinsic Tumor Suppressor through the Modulation of TNF-Mediated Proliferation.
Tattoli I; Killackey SA; Foerster EG; Molinaro R; Maisonneuve C; Rahman MA; Winer S; Winer DA; Streutker CJ; Philpott DJ; Girardin SE
Cell Rep; 2016 Mar; 14(11):2576-86. PubMed ID: 26971996
[TBL] [Abstract][Full Text] [Related]
3. The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.
Koblansky AA; Truax AD; Liu R; Montgomery SA; Ding S; Wilson JE; Brickey WJ; Mühlbauer M; McFadden RM; Hu P; Li Z; Jobin C; Lund PK; Ting JP
Cell Rep; 2016 Mar; 14(11):2562-75. PubMed ID: 26971998
[TBL] [Abstract][Full Text] [Related]
4. NLRX1 acts as tumor suppressor by regulating TNF-α induced apoptosis and metabolism in cancer cells.
Singh K; Poteryakhina A; Zheltukhin A; Bhatelia K; Prajapati P; Sripada L; Tomar D; Singh R; Singh AK; Chumakov PM; Singh R
Biochim Biophys Acta; 2015 May; 1853(5):1073-86. PubMed ID: 25639646
[TBL] [Abstract][Full Text] [Related]
5. The mitochondrial protein NLRX1 controls the balance between extrinsic and intrinsic apoptosis.
Soares F; Tattoli I; Rahman MA; Robertson SJ; Belcheva A; Liu D; Streutker C; Winer S; Winer DA; Martin A; Philpott DJ; Arnoult D; Girardin SE
J Biol Chem; 2014 Jul; 289(28):19317-30. PubMed ID: 24867956
[TBL] [Abstract][Full Text] [Related]
6. The mitochondrial Nod-like receptor NLRX1 modifies apoptosis through SARM1.
Killackey SA; Rahman MA; Soares F; Zhang AB; Abdel-Nour M; Philpott DJ; Girardin SE
Mol Cell Biochem; 2019 Mar; 453(1-2):187-196. PubMed ID: 30191480
[TBL] [Abstract][Full Text] [Related]
7. NLRX1 Negatively Regulates Group A
Aikawa C; Nakajima S; Karimine M; Nozawa T; Minowa-Nozawa A; Toh H; Yamada S; Nakagawa I
Front Cell Infect Microbiol; 2018; 8():403. PubMed ID: 30488027
[TBL] [Abstract][Full Text] [Related]
8. NLRX1 does not inhibit MAVS-dependent antiviral signalling.
Soares F; Tattoli I; Wortzman ME; Arnoult D; Philpott DJ; Girardin SE
Innate Immun; 2013; 19(4):438-48. PubMed ID: 23212541
[TBL] [Abstract][Full Text] [Related]
9. NLRX1 Regulation Following Acute Mitochondrial Injury.
Chu X; Wu S; Raju R
Front Immunol; 2019; 10():2431. PubMed ID: 31736938
[TBL] [Abstract][Full Text] [Related]
10. Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axis.
Walter L; Pujada A; Bhatnagar N; Bialkowska AB; Yang VW; Laroui H; Garg P
Oncotarget; 2017 Jan; 8(1):364-378. PubMed ID: 27861153
[TBL] [Abstract][Full Text] [Related]
11. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.
Sancho R; Jandke A; Davis H; Diefenbacher ME; Tomlinson I; Behrens A
Gastroenterology; 2010 Sep; 139(3):929-41. PubMed ID: 20638938
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis.
Hoshiko S; Kawaguchi M; Fukushima T; Haruyama Y; Yorita K; Tanaka H; Seiki M; Inatsu H; Kitamura K; Kataoka H
Cancer Res; 2013 Apr; 73(8):2659-70. PubMed ID: 23447577
[TBL] [Abstract][Full Text] [Related]
13. The regulatory role of NLRX1 in innate immunity and human disease.
Liu M; Liu K; Cheng D; Zheng B; Li S; Mo Z
Cytokine; 2022 Dec; 160():156055. PubMed ID: 36194971
[TBL] [Abstract][Full Text] [Related]
14. Nanog induces hyperplasia without initiating tumors.
Fischedick G; Wu G; Adachi K; Araúzo-Bravo MJ; Greber B; Radstaak M; Köhler G; Tapia N; Iacone R; Anastassiadis K; Schöler HR; Zaehres H
Stem Cell Res; 2014 Sep; 13(2):300-15. PubMed ID: 25173648
[TBL] [Abstract][Full Text] [Related]
15. NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-κB signaling.
Coutermarsh-Ott S; Simmons A; Capria V; LeRoith T; Wilson JE; Heid B; Philipson CW; Qin Q; Hontecillas-Magarzo R; Bassaganya-Riera J; Ting JP; Dervisis N; Allen IC
Oncotarget; 2016 May; 7(22):33096-110. PubMed ID: 27105514
[TBL] [Abstract][Full Text] [Related]
16. Epithelial cell-intrinsic Notch signaling plays an essential role in the maintenance of gut immune homeostasis.
Obata Y; Takahashi D; Ebisawa M; Kakiguchi K; Yonemura S; Jinnohara T; Kanaya T; Fujimura Y; Ohmae M; Hase K; Ohno H
J Immunol; 2012 Mar; 188(5):2427-36. PubMed ID: 22279105
[TBL] [Abstract][Full Text] [Related]
17. Conditional knockout of the leptin receptor in the colonic epithelium revealed the local effects of leptin receptor signaling in the progression of colonic tumors in mice.
Higurashi T; Endo H; Uchiyama T; Uchiyama S; Yamada E; Ohkubo H; Sakai E; Takahashi H; Maeda S; Wada K; Natsumeda Y; Hippo Y; Nakajima A; Nakagama H
Carcinogenesis; 2014 Sep; 35(9):2134-41. PubMed ID: 24958593
[TBL] [Abstract][Full Text] [Related]
18. NLR in eXile: Emerging roles of NLRX1 in immunity and human disease.
Pickering RJ; Booty LM
Immunology; 2021 Mar; 162(3):268-280. PubMed ID: 33314068
[TBL] [Abstract][Full Text] [Related]
19. NLRX1 Is a Multifaceted and Enigmatic Regulator of Immune System Function.
Nagai-Singer MA; Morrison HA; Allen IC
Front Immunol; 2019; 10():2419. PubMed ID: 31681307
[TBL] [Abstract][Full Text] [Related]
20. NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells.
Nagai-Singer MA; Morrison HA; Woolls MK; Leedy K; Imran KM; Tupik JD; Allen IC
Front Oncol; 2023; 13():1155831. PubMed ID: 37342194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
